Cargando…

Impact of capitation on outpatient expenses among patients with diabetes mellitus in Tianjin, China: a natural experiment

OBJECTIVES: Capitation policy, a new medical insurance settlement method implemented on 1 January 2014 in Tianjin, China, aimed to control unreasonable increases in medical costs. The goal of the current study was to evaluate the impact of capitation on outpatient expenses among patients with diabet...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Yanan, Chen, Jiageng, Jing, Xiyue, Shi, Xinjun, Chen, Yunfeng, Deng, Xiaowei, Li, Changping, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596975/
https://www.ncbi.nlm.nih.gov/pubmed/31229998
http://dx.doi.org/10.1136/bmjopen-2018-024807
_version_ 1783430527424921600
author Dong, Yanan
Chen, Jiageng
Jing, Xiyue
Shi, Xinjun
Chen, Yunfeng
Deng, Xiaowei
Li, Changping
Ma, Jun
author_facet Dong, Yanan
Chen, Jiageng
Jing, Xiyue
Shi, Xinjun
Chen, Yunfeng
Deng, Xiaowei
Li, Changping
Ma, Jun
author_sort Dong, Yanan
collection PubMed
description OBJECTIVES: Capitation policy, a new medical insurance settlement method implemented on 1 January 2014 in Tianjin, China, aimed to control unreasonable increases in medical costs. The goal of the current study was to evaluate the impact of capitation on outpatient expenses among patients with diabetes mellitus and provide scientific evidence for health policy-makers. DESIGN: A natural experiment. SETTING: The medical insurance database of Tianjin from 1 January 2010 to 31 December 2014. PARTICIPANTS: In total, 35 529 records were included, comprising 9646 records in the pilot group (4907 records in 2014 and 4739 records in 2013) and 25 883 records in the control group (9814 records in 2014 and 16 069 records in 2013). MAIN OUTCOME MEASURES: The outcome variables included annual total outpatient expenses, drug expenses, examination expenses, treatment expenses and other expenses. RESULTS: Capitation produced an increase in total outpatient expenses of ¥1993.76 (95% CI, ¥1643.74 to ¥2343.77) in the pilot group relative to the control group. There was also an increase in drug expenses of ¥1904.30 (95% CI, ¥1578.63 to ¥2229.96) after the implementation of capitation. An increase in examination expenses of ¥44.90 (95% CI, ¥19.11 to ¥70.68) was found in the pilot group versus the control group. Capitation also produced an increase in treatment expenses of ¥3.55 (95% CI, ¥1.01 to ¥6.09) and an increase in other expenses of ¥43.46 (95% CI, ¥26.81 to ¥60.11) in the pilot group versus the control group. CONCLUSION: Compared with those who participated in the ‘control’ policy, outpatient expenses of patients enrolled in capitation increased significantly. The increases were due to the actual needs of patients, changes in drug directories, and the autonomy and independence of hospitals. It is necessary for the government, policy-makers, hospitals, doctors, patients and supervisory agencies to improve the capitation policy.
format Online
Article
Text
id pubmed-6596975
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-65969752019-07-18 Impact of capitation on outpatient expenses among patients with diabetes mellitus in Tianjin, China: a natural experiment Dong, Yanan Chen, Jiageng Jing, Xiyue Shi, Xinjun Chen, Yunfeng Deng, Xiaowei Li, Changping Ma, Jun BMJ Open Health Policy OBJECTIVES: Capitation policy, a new medical insurance settlement method implemented on 1 January 2014 in Tianjin, China, aimed to control unreasonable increases in medical costs. The goal of the current study was to evaluate the impact of capitation on outpatient expenses among patients with diabetes mellitus and provide scientific evidence for health policy-makers. DESIGN: A natural experiment. SETTING: The medical insurance database of Tianjin from 1 January 2010 to 31 December 2014. PARTICIPANTS: In total, 35 529 records were included, comprising 9646 records in the pilot group (4907 records in 2014 and 4739 records in 2013) and 25 883 records in the control group (9814 records in 2014 and 16 069 records in 2013). MAIN OUTCOME MEASURES: The outcome variables included annual total outpatient expenses, drug expenses, examination expenses, treatment expenses and other expenses. RESULTS: Capitation produced an increase in total outpatient expenses of ¥1993.76 (95% CI, ¥1643.74 to ¥2343.77) in the pilot group relative to the control group. There was also an increase in drug expenses of ¥1904.30 (95% CI, ¥1578.63 to ¥2229.96) after the implementation of capitation. An increase in examination expenses of ¥44.90 (95% CI, ¥19.11 to ¥70.68) was found in the pilot group versus the control group. Capitation also produced an increase in treatment expenses of ¥3.55 (95% CI, ¥1.01 to ¥6.09) and an increase in other expenses of ¥43.46 (95% CI, ¥26.81 to ¥60.11) in the pilot group versus the control group. CONCLUSION: Compared with those who participated in the ‘control’ policy, outpatient expenses of patients enrolled in capitation increased significantly. The increases were due to the actual needs of patients, changes in drug directories, and the autonomy and independence of hospitals. It is necessary for the government, policy-makers, hospitals, doctors, patients and supervisory agencies to improve the capitation policy. BMJ Publishing Group 2019-06-21 /pmc/articles/PMC6596975/ /pubmed/31229998 http://dx.doi.org/10.1136/bmjopen-2018-024807 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Health Policy
Dong, Yanan
Chen, Jiageng
Jing, Xiyue
Shi, Xinjun
Chen, Yunfeng
Deng, Xiaowei
Li, Changping
Ma, Jun
Impact of capitation on outpatient expenses among patients with diabetes mellitus in Tianjin, China: a natural experiment
title Impact of capitation on outpatient expenses among patients with diabetes mellitus in Tianjin, China: a natural experiment
title_full Impact of capitation on outpatient expenses among patients with diabetes mellitus in Tianjin, China: a natural experiment
title_fullStr Impact of capitation on outpatient expenses among patients with diabetes mellitus in Tianjin, China: a natural experiment
title_full_unstemmed Impact of capitation on outpatient expenses among patients with diabetes mellitus in Tianjin, China: a natural experiment
title_short Impact of capitation on outpatient expenses among patients with diabetes mellitus in Tianjin, China: a natural experiment
title_sort impact of capitation on outpatient expenses among patients with diabetes mellitus in tianjin, china: a natural experiment
topic Health Policy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596975/
https://www.ncbi.nlm.nih.gov/pubmed/31229998
http://dx.doi.org/10.1136/bmjopen-2018-024807
work_keys_str_mv AT dongyanan impactofcapitationonoutpatientexpensesamongpatientswithdiabetesmellitusintianjinchinaanaturalexperiment
AT chenjiageng impactofcapitationonoutpatientexpensesamongpatientswithdiabetesmellitusintianjinchinaanaturalexperiment
AT jingxiyue impactofcapitationonoutpatientexpensesamongpatientswithdiabetesmellitusintianjinchinaanaturalexperiment
AT shixinjun impactofcapitationonoutpatientexpensesamongpatientswithdiabetesmellitusintianjinchinaanaturalexperiment
AT chenyunfeng impactofcapitationonoutpatientexpensesamongpatientswithdiabetesmellitusintianjinchinaanaturalexperiment
AT dengxiaowei impactofcapitationonoutpatientexpensesamongpatientswithdiabetesmellitusintianjinchinaanaturalexperiment
AT lichangping impactofcapitationonoutpatientexpensesamongpatientswithdiabetesmellitusintianjinchinaanaturalexperiment
AT majun impactofcapitationonoutpatientexpensesamongpatientswithdiabetesmellitusintianjinchinaanaturalexperiment